FLXI:XETRA:XETRA-Franklin Libertyshares ICAV - Franklin Ftse India Ucits ETF (EUR)

ETF | Others |

Last Closing

USD 43.37

Change

+0.18 (+0.42)%

Market Cap

USD 0.60B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.30 (+0.57%)

USD 511.43B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.42%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.16 (+0.55%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.48%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 100.46B
8R80:XETRA Amundi Index Solutions - Amund..

+0.46 (+0.32%)

USD 98.85B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.58 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.20 (+0.88%)

USD 79.79B

ETFs Containing FLXI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.25% 91% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.25% 91% A- 88% B+
Trailing 12 Months  
Capital Gain 38.23% 93% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.23% 93% A 91% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.60% 92% A 89% A-
Dividend Return 17.60% 92% A 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.92% 23% F 35% F
Risk Adjusted Return 93.00% 95% A 95% A
Market Capitalization 0.60B 71% C- 62% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.